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Abstract
Background: Male partner HIV testing and counseling (HTC) is associated with enhanced uptake of prevention
of mother-to-child HIV transmission (PMTCT), yet male HTC during pregnancy remains low. Identifying settings
preferred by pregnant women and their male partners may improve male involvement in PMTCT.
Methods: Participants in a randomized clinical trial (NCT01620073) to improve male partner HTC were interviewed
to determine whether the preferred male partner HTC setting was the home, antenatal care (ANC) clinic or VCT
center. In this nested cross sectional study, responses were evaluated at baseline and after 6 weeks. Differences
between the two time points were compared using McNemar’s test and correlates of preference were determined
using logistic regression.
Results: Among 300 pregnant female participants, 54 % preferred home over ANC clinic testing (34.0 %) or VCT
center (12.0 %). Among 188 male partners, 68 % preferred home-based HTC to antenatal clinic (19 %) or VCT (13 %).
Men who desired more children and women who had less than secondary education or daily income < $2 USD
were more likely to prefer home-based over other settings (p < 0.05 for all comparisons). At 6 weeks, the majority of
male (81 %) and female (65 %) participants recommended home over alternative HTC venues. Adjusting for
whether or not the partner was tested during follow-up did not significantly alter preferences.
Conclusions: Pregnant women and their male partners preferred home-based compared to clinic or VCT-center
based male partner HTC. Home-based HTC during pregnancy appears acceptable and may improve male testing
and involvement in PMTCT.
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Introduction
Male partner involvement in prevention of mother-to-
child HIV transmission (PMTCT) has been associated
with enhanced uptake of PMTCT interventions and in-
fant HIV-free survival [1, 2]. Male partner HIV testing is
a critical link to male involvement in PMTCT and other
aspects of reproductive health for sexually active couples
in stable relationships. For example, male home-based
HIV testing and counseling (HTC) has been associated with
decreases in HIV related high-risk sexual behaviors [3, 4].
However, despite the availability ofmultiple options, including
mobile and fixed voluntary counseling and testing (VCT) cen-
ters, antenatal care (ANC) clinic and home-based HTC, less
than one-third of male partners of pregnant women undergo
individual or couple-basedHTC in sub-SaharanAfrica [5–8].
Uptake of male partner HTC during the antenatal
period is low [7, 9, 10]. Current options for HTC include
VCT center-based testing, antenatal care (ANC) clinic-
based testing, or home based testing (HBHCT). As a
client-initiated approach, VCT center-based testing may
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face barriers due to stigma and vulnerability because of
attitudes or assumptions regarding individuals who re-
quest HIV testing. Individuals and couples may perceive
seeking VCT testing as an indication of high-risk sexual
behavior. These barriers may be lowered in routinized
HIV testing models, such as provider-initiated testing
and counseling (PITC) that is administered to all indi-
viduals seeking care [11]. VCT center testing may not
improve disclosure of HIV results since the testers are
rarely counseled and tested as couples [12]. ANC clinic-
based male partner HTC has remained low despite impro-
visations like providing male partner invitation letters or
efforts to make ANC settings male-friendly [7, 10, 13].
Furthermore, while ANC male testing provides an op-
portunity for couple HTC, most men do not accom-
pany their pregnant partners to ANC because this is
considered a female domain [14]. Pregnant women
and their male partners also cite facility space limita-
tions and staff attitudes as barriers to male partner
testing in the ANC clinic [15, 16].
Home-based HTC (HBHTC) has consistently had high
acceptability (>70 %), particularly among individuals in
stable relationships [17, 18]. Provider-initiated home-
based HTC has been shown to increase HTC of families
and partners of HIV-infected individuals [19]. In our re-
cent randomized trial that compared home versus clinic-
based male partner testing during pregnancy in Kenya,
there was over a 2-fold increase in male partner access
and more men underwent HTC at home (85 %) than in
the clinic (36 %) [20]. Home testing may be advanta-
geous as it enables facilitated disclosure of HIV results
and increases access to male partner for couple testing,
which are important concerns of women who undergo
individual HTC during pregnancy [21]. Despite the suc-
cess of home-based testing in a few research studies in
reaching male partners, this method has not become
standard practice for antenatal care. It is therefore im-
portant to determine preferences of men for HTC venue,
so as to inform programs regarding where to focus male
HIV testing resources and achieve greatest impact.
In order to determine the most acceptable setting for
male partner HTC, we interviewed participants in a ran-
domized trial on their preferred setting for male partner
HTC, either home-based, VCT center-based or ANC
clinic-based HTC. We compared setting preference at
baseline and at a 6-week follow-up visit and evaluated the
preferred male partner testing settings among participants
randomized to either clinic-based or home-based testing.
Methods
Study design and setting
This was a cross-sectional study nested within a ran-
domized clinical trial conducted in a rural high HIV-
prevalence setting in Nyanza province, Kenya at the
Ahero Sub-district Hospital. Participating couples were
followed up six weeks after enrollment.
Subject selection
Study participants were pregnant women and their male
partners. Women were screened during their first ante-
natal care (ANC) clinic visit and randomized to either a
home visit with their male partner or an invitation to
bring their male partner to the ANC clinic for couple
HTC. Male partners were reached during either home or
clinic visit, as described elsewhere [20]. Women were
18 years or older, in stable relationships, unaccompanied
by their male partners during the ANC clinic visit and had
not received couple HTC in the index pregnancy, prior to
this first ANC visit. HIV-positive women were eligible if
they had not previously disclosed their HIV status to their
male partners. Male participants were 18 years or older
partners of participating pregnant women.
Study procedures
Following informed consent and enrollment, trained
community health workers, who were also experienced
HIV counselors, interviewed participants in both study
arms using Audio Computer Assisted Self Interview
(ACASI) on a Samsung® Google Nexus smartphone.
After completing the antenatal procedures, a scheduled
6-week follow-up visit was conducted either at home or
at the clinic during which an exit ACASI was also ad-
ministered. The ACASI were conducted privately either
in a room at the clinic or within the participant homes
in either English or Dholuo (the local dialect). Partici-
pants were interviewed on a variety of topics, including
preferred setting of male testing, reproductive health de-
cisions, HIV risk factors and uptake of HIV prevention
interventions. To determine the type of preferred test-
ing, participants were asked at baseline and follow-up if
they favored either home-based male partner testing,
antenatal clinic-based male partner testing or VCT
center-based testing. ACASI data were collected on an
Open Data Kit (ODK) platform.
Sample size and study outcomes
The randomized trial was powered to detect a 50 % in-
crease in male partner tracing and uptake of couple
HTC between the clinic and home-based arms. This sec-
ondary analysis included all study participants who were
interviewed both at baseline and at follow-up. The pri-
mary study outcome was the preferred setting of male
HTC at baseline and follow-up. Secondary outcomes
were correlates of each male HTC setting stratified by
gender and couple HTC status and changes in preferred
male HTC setting between enrolment and the 6-week
follow-up visit.
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Statistical analysis
Smartphone ACASI data were saved on ODK Collect,
and imported into Stata® 12, which was used for ana-
lyses. We evaluated the proportions of participant pref-
erence for each of the three settings of male partner
testing during enrollment and follow-up stratified by
gender. Chi-squared tests and 95 % confidence intervals
were used to test for significant differences between the
different settings at baseline and follow-up. Logistic re-
gression analyses were conducted to identify correlates
of setting preference for each gender and to adjust for
partner testing status. McNemar’s test was used to com-
pare changes in setting preferences between baseline
and follow-up.
Ethical statement
The Institutional Review Boards at University of Washing-
ton, University of Nairobi and Kenyatta National Hospital
approved the study protocol. All study participants
provided written informed consent in English or Dholuo.
The community advisory board provided oversight and
advice. The parent study protocol was registered at
ClinicalTrials.gov, registration number, NCT01620073.
Results
Sociodemographic characteristics
Between July 2012 and February 2013, 300 eligible preg-
nant women were randomized and assigned to home-
based (n = 150) or clinic-based (n = 150) male partner
HTC. One hundred and eighty-eight male partners of
these women were enrolled either at home (n = 133,
70.7 %) or antenatal care (ANC) clinic (n = 55, 29.3 %)
(Fig. 1). This difference in male enrollment reflects the
higher effectiveness of the HBHTC strategy in this trial.
Participating men had a median age of 29 years (inter-
quartile range [IQR] 25, 35) and 42 % of these men had
secondary or higher level of education. Most men
(87.8 %) were in monogamous marital relationships. The
majority of men (60.1 %) reported a daily household in-
come of > $2 USD. Thirty-one (17.0 %) men reported
concurrency, while 20 (10.6 %) men perceived their
female partners as having concurrent partnerships. Dur-
ing the preceding six months, 34 (18.1 %) men reported
experiencing physical threat from their female partner
while 28 (14.9 %) received threats from other partner(s)
or family member. Few men reported experiencing
forced sex over the preceding six months either from
their current sex partner (2.7 %) or another partner or
family member (1.1 %). HIV prevalence among the par-
ticipating male partners was 16 %. Most men reported
that their female partners were multiparous (59 %) and
desired more children (84.0 %). About two-thirds of
men (68.1 %) reported no contraceptive use by their
partner prior to the index pregnancy.
The baseline characteristics of women enrolled in the
primary study have previously been described and are
summarized here (Table 1) [20]. Compared to male part-
ners, women were younger with a median age of 22 years
(IQR:20–26), less educated, with only 32.7 % reporting
secondary or higher level of education, and had a lower
income, with 74.7 % earning a daily household income
< $2 USD. Almost a third of women (28.7 %) perceived
their partners were having concurrent partnerships. Dur-
ing the preceding six months, a higher proportion of
women (30.7 %) than men reported experiencing phys-
ical threat either from their current partner (76.1 %) or
another partner or other person including family mem-
bers (23.9 %). Overall, 16 % of the women were HIV-
infected. Over half (56.0 %) of the women had not used
any contraceptive method prior to the index pregnancy.
Baseline preferences on male partner HIV testing setting
Most participants preferred home-based (59.4 %) over
ANC clinic-based (28.3 %) and VCT center-based (12.3 %)
male partner HTC during pregnancy (Table 2). In addition,
more men than women (68.1 vs. 54.0 %, p = 0.002) pre-
ferred home-based male partner HTC. Male partners were
significantly more likely than pregnant women to prefer
home-based HTC. After adjusting for partner HIV status,
male partners remained significantly more likely than
women to prefer HBHCT. Fewer men than women
Fig. 1 Enrollment and follow-up of pregnant women and their
male partners
Osoti et al. BMC Infectious Diseases  (2015) 15:298 Page 3 of 7
(19.2 % vs. 34.0 %, p < 0.001) preferred ANC clinic-
based HTC. VCT center-based testing was the least
preferred setting of male partner testing by both men
(12.8 %) and women (12.0 %) and the difference was
not statistically significant. The preferences did not
vary by partner testing status.
Correlates of preferred settings for male partner testing
Men were more likely to prefer HBHTC testing if they
desired more children [odds ratio (OR) 3.47, 95 % confi-
dence interval (CI): 1.53-7.89) (Table 3). This association
remained significant after adjusting for partner HIV test-
ing and randomization arm (adjusted OR 3.51, 95 % CI:
1.54-7.97, P = 0.003). Women who had primary or lower
level of education were more likely than those with
higher education to favor HBHCT for male partners and
those who had a daily income < $2 USD were also more
likely to prefer HBHCT for male partner testing. Women
who perceived their partners as having concurrent partners
were more likely to prefer HBHTC (OR = 2.35, 95 % CI:
1.39-3.99) and those who reported physical threat were
also more likely to prefer HBHTC for male testing
(OR1.44, 95 % CI: 1.06 to 1.95). HIV-infected women were
more likely than HIV-uninfected women to favor male
partner HBHTC (OR 2.35, 95 % CI: 1.20- 4.60).
Changes in preferred settings for male partner testing
Overall, male and female participants were significantly
more likely to prefer HBHTC for male testing at follow-
up (71.0 %) compared to enrollment (59.2 %), (OR 1.98,
95 % CI: 1.43-2.78) irrespective of the study arm
(Table 4). Men were twice as likely to favor male
HBHTC during follow-up (80.9 %) compared to
Table 1 Baseline characteristics of study population, both
pregnant women and their male partners (N = 488)
Characteristic Women
N = 300





Age (years) 22 (20,26) 29 (25,35)
Age group (years)
≤19 65 (21.7) 1 (0.5)
20-24 140 (46.7) 33 (17.6)
25-29 57 (19.0) 64 (34.0)
30-34 27 (9.0) 41 (21.8)
35-39 8 (2.7) 26 (13.8)
≥40 3 (1.0) 23 (12.2)
Highest education level
Primary or lower 202 (67.3) 109 (58.0)
Secondary (some or
complete)
80 (26.7) 57 (30.3)
Post secondary 18 (6.0) 22 (11.7)
Marital status
Monogamous 262 (87.3) 165 (87.8)
Polygamous 25 (8.3) 17 (9.0)
Unmarried (Single,
widow or cohabiting)




76 (25.3) 113 (60.1)
Sexual partnerships
Self report of concurrency
past 6 months
8 (2.7) 31 (17.0)
Perceived partner
concurrency
86 (28.7) 20 (10.6)
Physically threatened past 6 months
None 208 (69.3) 126 (67.0)
Study partner 70 (23.3) 34 (18.1)
Other partner or family
member
22 (7.3) 28 (14.9)
Experienced forced sex
None 290 (96.7) 181 (96.3)
Study partner 8 (2.7) 5 (2.7)
Other partner or family
member
2 (0.6) 2 (1.1)
HIV status
HIV positive 48 (16.0) 30 (16.0)
Number of previous pregnancies
(or of partner)
None 51 (17.0) 28 (14.9)
1 86 (28.7) 49 (26.1)
≥2 163 (54.3) 111 (59.0)
Desire of more children
Table 1 Baseline characteristics of study population, both
pregnant women and their male partners (N = 488) (Continued)
None 62 (20.7) 30 (16.0)
Desire more children 238 (79.3) 158 (84.0)
Contraceptive use (or use by partner)
prior to current pregnancy
None 168 (56.0) 128 (68.1)
Hormonal 124 (41.3) 45 (24.0)
Withdrawal, condom,
sterilization
8 (2.7) 15 (8.0)
IQR interquartile range
Table 2 Differences in baseline preferences on setting of male
partner HIV testing by gender
Male Female 0R 95 % CI p-value
Home 128 (68.1) 162 (54.0) 1.81 1.24-2.66 0.002
Clinic 36 (19.2) 102 (34.0) 0.46 0.30-0.71 <0.001
VCT 24 (12.8) 36 (12.0) 1.07 0.62-1.86 0.796
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enrollment (68.1 %), (OR 2.20, 95 % CI: 1.27-3.94)
(Table 4). Similarly, participating women were signifi-
cantly more likely to favor male HBHTC at follow-up
compared to baseline, (OR 1.89, 95 % CI: 1.26-2.89).
Men were less likely to prefer ANC clinic-based or VCT
center-based testing at follow-up. However, the decrease was
not statistically significant. Women were significantly 45 %
less likely at follow-up (25.3 %) than at enrollment (34.0 %)
to favor ANC clinic-based male testing. Fewer women pre-
ferred VCT center-based testing at follow-up, although the
difference was not statistically significant. Adjusting for part-
ner testing status and study arm did not significantly alter
the changes in preferences for male partner testing.
Discussion
In this study, both pregnant women and their male part-
ners preferred home-based HIV testing and counseling
(HTC) to the currently recommended antenatal (ANC)
clinic setting or widely available VCT center-based testing.
This suggests that higher HIV testing rates for male part-
ners may be achieved through a home-based approach. Ef-
forts to increase male partner involvement in PMTCT
programs should consider offering women in ANC
opportunities to have home visits for male partner HTC.
Home-based male partner testing may influence
PMTCT program effectiveness given some evidence
that male partner involvement is associated with im-
proved PMTCT uptake and infant HIV-free survival
[1, 2, 7, 22].
We also found that more men than women preferred
male partner HBHTC. This may have been because most
men were enrolled and tested at home. However, this
preference remained after adjusting for randomization
arm and male partner HIV status. The high male
partner preference for HBHTC compared to alternate
settings is consistent with high uptake of male HTC
reported in home-based HTC studies in South Africa
[23] and Zambia [24, 25]. Men may prefer home test-
ing due to the convenience, privacy and ease of
access. In addition, with couples HBHTC mutual dis-
closure may reduce HIV-related stigma and increased
partner support in preventing HIV acquisition by the
HIV-uninfected partner and linkage to care for the
HIV-infected partner or couple.
The other salient finding from this study was that de-
sire for more children was substantially and significantly
Table 3 Correlates of preferred setting of male partner HIV testing at baseline by gender
Characteristic Home Clinic VCT
Male Female Male Female Male Female
OR 95 % CI OR 95 % CI OR 95 % CI OR 95 % CI OR 95 % CI OR 95 % CI
Age ≥25 years 1.63 0.77-3.47 1.44 0.88-2.36 0.72 0.30-1.72 0.91 0.55–1.53 0.62 0.23-1.64 0.48 0.21-1.12
Education≥ Secondary 1.04 0.56-1.92 O.47 0.29-0.77* 1.30 0.63-2.67 1.78 1.08–2.92* 0.65 0.27-1.58 1.56 0.77-3.14
Married 1.69 0.55-5.13 1.84 0.78-4.31 0.51 0.00-2.13 0.73 0.30–1.77 0.87 0.00-3.67 0.32 0.00-1.95
Income > $2 USD 0.73 0.39-1.35 0.53 0.31-0.90* 1.70 0.82-3.50 1.38 0.81–2.35 0.90 0.38-2.15 2.07 1.01-4.25*
Concurrency 1.41 0.59-3.27 6.19 0.75-50.9 0.60 0.20-1.76 0.00 0.00–0.91* 1.01 0.34-3.06 1.05 0.00-6.81
Perceived concurrency 2.00 0.64-6.26 2.35 1.39-3.99* 1.00 – 0.58 0.33-1.01 1.85 0.56-6.09 0.36 0.14-0.97*
Physically threat 1.29 0.93-1.79 1.44 1.06-1.95* 0.95 0.70-1.29 0.92 0.68-1.23 0.50 0.24-1.05 0.22 0.07-0.71*
Forced sex 1.43 0.37-5.54 1.22 0.49-3.01 0.63 0.10-3.82 0.70 0.24-2.06 0.89 0.15-5.24 1.20 0.37-3.87
HIV positive 0.92 0.40-2.12 2.35 1.20-4.60* 1.35 0.53-3.45 0.46 0.22-0.96* 0.73 0.20-2.64 0.63 0.21-1.86
≥1 previous pregnancy 1.03 0.89-1.19 1.08 0.95-1.23 0.94 0.79-1.13 0.95 0.83-1.10 1.03 0.85-1.24 0.92 0.74-1.14
Desire more children 3.47 1.53-7.89* 1.49 0.86-2.57 0.50 0.21-1.22 1.12 0.63-2.00 0.29 0.11-0.78* 0.36 0.17-0.75*
Contraceptive use 1.01 0.98-1.04 0.87 0.71-1.06 0.98 0.82-1.17 1.08 0.89-1.34 1.00 0.96-1.03 0.86 0.86-1.55
Comparison of Home versus Others, Clinic versus others and VCT versus others
OR odds ratio, CI confidence interval
*P < 0.05
Table 4 Changes in preferred model of male partner HIV testing by gendera
Male Female
Setting Baseline Follow-up OR 95 % CI p-value Baseline Follow-up OR 95 % CI p-value
Home 68.1 % 80.9 % 2.20 1.27-3.94 0.004** 54.0 % 65.3 % 1.89 1.26-2.89 0.001**
Clinic 19.5 % 11.9 % 0.61 0.38-0.98 0.039** 34.0 % 25.3 % 0.55 0.35-0.87 0.006**
VCT 13.0 % 7.6 % 0.50 0.21-1.12 0.068 12.2 % 9.5 % 0.72 0.39-1.31 0.258
aMcNemar’s test OR odds ratio, CI confidence interval
**P < 0.05
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associated with preference for home-based male partner
testing among male partners. This finding is important
because home-based testing may provide an opportunity
to protect couples against HIV acquisition in subsequent
pregnancies and enhance PMTCT. Similarly, the majority
of participating women and especially those who preferred
home partner testing had a lower level of education and
low daily household income. Therefore, a home-based ap-
proach may reach a majority of women and their partners
in low-resource settings. It is possible that women with
higher education level and income may have better nego-
tiation skills for ANC clinic testing or have partners with
similar or higher socioeconomic status who understand
and support ANC clinic-based testing.
Concurrent and multiple partnerships increase the risk
of HIV acquisition. In this study women were less likely
to report concurrency and more likely to perceive con-
currency than men and polygamy was low. The finding
that pregnant women who reported perceived partner
concurrency were more likely to favor home-based male
partner testing suggests that such women were con-
cerned about their partner’s HIV status and if in polyg-
amous relationships would prefer HI testing of all
partners at home. Specifically, they may have anticipated
that a home-based approach was more likely to result in
knowledge of their male partner’s HIV status. Women
who reported physical threat were also more likely to
favor home-based male partner testing most likely due
to similar reasons in addition to possible reassurance of
couple HTC and support. Therefore, home-based testing
may reach women who consider themselves at greater
risk of exposure to HIV from their partners and those
who may need support for mutual disclosure as seen in
other studies [21]. HIV-infected women were more likely
to favor home-based male partner HTC possibly because
such mothers may have known their HIV status earlier
and needed support for couple HTC and mutual disclos-
ure of results facilitated by home visits.
While ANC clinic-based testing remains the main set-
ting of male partner testing, both women and men, but
particularly the men, were less likely to favor ANC-
based testing. This may explain the persistently low male
partner and couple ANC testing rates seen in several
studies despite the campaigns and motivation to make
clinics male-friendly [7, 10, 13]. Additionally, very few
pregnant women and few male partners preferred VCT-
based male HTC. In other studies VCT testers were
mostly single adults [12, 26], with few testing as couples.
Thus, VCT -based testing may not encourage couples
counseling and mutual disclosure of results. In our
study, VCT-based testing was preferred by women who
had higher income and considered themselves to be at a
low risk of HIV acquisition (no perceived concurrency
and no desire for additional children). This is contrary
to a South African study which found that repeat VCT-
based testers tended to be at greater risk of HIV,
although it is important to note that these testers were
predominantly single [26].
This study had several strengths. It was conducted in a
low-resource setting with high HIV burden where male
partner testing is low. Therefore, its findings can be gener-
alized to similar settings with similar stable heterosexual
partnerships. The three HTC options presented to partici-
pants in this study are the most commonly available
modes of HTC in such settings, which also contributes to
its generalizability. The study had some limitations. Spe-
cifically, we did not provide all of the different modes of
HTC but only asked participants about their HTC prefer-
ences. Therefore, the study question captured intention to
test rather than actual testing of male partners in the three
different HTC models. We offered home-based testing to
half of women and their partners and the other half were
offered ANC clinic-based testing (no one was offered
VCT center-based testing). This may have influenced par-
ticipant responses and preferences. However, both arms of
the study preferred home-based testing. Finally, the study
was not designed to evaluate the reasons behind the pref-
erence of different settings for male partner HTC. Add-
itional questions on the impact of this strategy may be
assessed in long-term and qualitative studies.
Conclusions
Pregnant women and their male partners were more
likely to prefer a home-based approach for male partner
HTC during pregnancy when given the options of
home-based, ANC clinic-based or VCT center-based
testing. To increase male partner testing, programs
should provide pregnant women and their male partners
with an opportunity for home visits for male partner
testing during pregnancy. Future studies could evaluate
this programmatic impact on PMTCT and other HIV
prevention and treatment outcomes in the population.
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